FDA.reportPublic FDA data

Compound W Gel

Manufacturer
Central Texas Community Health Centers
Effective date
2017-12-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:53:13

Label at a glance#

ProductCompound W
Active ingredientSALICYLIC ACID
Label structure9 sections

Dosage and administration

wash affected area may soak wart in warm water for 5 minutes dry area thoroughly by squeezing tube gently, apply one drop at a time to sufficiently cover each wart let dry repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Compound W®
Salicylic Acid Wart Remover

MAXIMUM STRENGTH
FAST ACTING GEL

NET WT 0.25 OZ (7 g)

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 17% w/w

Purpose

OTC - PURPOSE SECTION

Wart remover

Use

INDICATIONS & USAGE SECTION

  • for the removal of common and plantar warts.
  • the common wart is easily recognized by the rough "cauliflower-like" appearance on the surface.
  • the plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

Warnings

WARNINGS SECTION

For external use only.

Flammable. Keep away from fire and flame.

Do not use

OTC - DO NOT USE SECTION

  • on irritated skin or on any area that is infected or reddened.
  • on moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes.
  • if you have diabetes or poor blood circulation.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes. If product gets into the eye, flush with water for 15 minutes.
  • avoid inhaling vapors
  • cap tightly and store at room temperature away from heat

Stop use and ask a doctor if

OTC - STOP USE SECTION

discomfort persists.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash affected area
  • may soak wart in warm water for 5 minutes
  • dry area thoroughly
  • by squeezing tube gently, apply one drop at a time to sufficiently cover each wart
  • let dry
  • repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks

Inactive ingredients

INACTIVE INGREDIENT SECTION

alcohol, camphor, castor oil, ethyl acetate, hydroxypropyl cellulose, hypophosphorous acid, isopropanol, nitrocellulose, polysorbate 80

Questions?

OTC - QUESTIONS SECTION

1-800-443-4908 CompoundW.com

©2016 Distributed by Medtech Products Inc.
Tarrytown, NY 10591
A Prestige Brands Company
Made in Brazil

PRINCIPAL DISPLAY PANEL - 7 gm Tube Box Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CommUnityCare Federally Qualified Health Centers

COMPOUND
W GEL 7 GM

Date:

Name:
Dr.

APPLY 1 DROP TO CLEAN, DRY WART 1-2 TIMES DAILY.
REPEAT UP TO 12 WEEKS.

1-1-11

123456

Compound W GEL 7gm NDC 76413-348-07

Batch: 123456
Lot: 123456
Exp: 1-1-11
MEDTECH

Federal law prohibits the transfer of this drug to any other person than the patient for whom prescribed.

PRINCIPAL DISPLAY PANEL - 7 gm Tube Box Label
PRINCIPAL DISPLAY PANEL - 7 gm Tube Box Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
210140Compound W 17 % Topical GelPSN1
312880salicylic acid 17 % Topical GelPSN1
210140salicylic acid 0.17 MG/MG Topical Gel [Compound W brand of salicylic acid]SBD1
312880salicylic acid 0.17 MG/MG Topical GelSCD1
210140Compound W brand of salicylic acid 0.17 MG/MG Topical GelSY1
210140Compound W brand of salicylic acid 17 % Topical GelSY1
312880salicylic acid 17 % Topical GelSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
76413-348-072020-01-31C16284748780-19d75b9d0-9b23-f424-e053-dadaa90a57ceCompound W Gel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76413-348-07Compound W7 g in 1 TUBEGEL71
76413-348-07Compound W1 in 1 BOXGEL11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76413-348COMPOUND W (SALICYLIC ACID) GEL [CENTRAL TEXAS COMMUNITY HEALTH CENTERS]1Legacy NDC, 2 package rows20171205_e8938dc4-25a7-4edb-9906-784b78a47990.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76413-34876413-348-07
63029-595

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
ALCOHOL3K9958V90MIACT
CAMPHOR (NATURAL)N20HL7Q941IACT
CASTOR OILD5340Y2I9GIACT
ETHYL ACETATE76845O8NMZIACT
HYDROXYPROPYL CELLULOSE (1200000 MW)RFW2ET671PIACT
HYPOPHOSPHOROUS ACID8B1RL9B4ZJIACT
ISOPROPYL ALCOHOLND2M416302IACT
PYROXYLINKYR8BR2X6OIACT
POLYSORBATE 806OZP39ZG8HIACT

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Compound WSALICYLIC ACIDMedtech Products Inc.0b25a21a-d843-49f7-a2cc-11958fd66ac42025-10-23WarningsExact identifier
ndc (product): 63029-595
c606a3ac-95fd-4be7-952f-f01dbbf0a40ce8938dc4-25a7-4edb-9906-784b78a479902017-12-04WarningsExact identifier
spl id: c606a3ac-95fd-4be7-952f-f01dbbf0a40c
spl set id: e8938dc4-25a7-4edb-9906-784b78a47990

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.